Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers
Gustavo Arango-Argoty(AstraZeneca (South Korea)), Etai Jacob(AstraZeneca (United States)), Ioannis Kagiampakis(Johns Hopkins University), Ross E. Stewart(AstraZeneca (United Kingdom)), Arijit Patra(UCB Pharma (United States)), Elly Kipkogei(AstraZeneca (United States))
Cited by 2
Related Papers
DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data
|Microbiome|2018|962
An in-depth map of polyadenylation sites in cancer
|Nucleic Acids Research|2012|151
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
|Cancer Cell|2018|126
NanoARG: a web service for detecting and contextualizing antimicrobial resistance genes from nanopore-derived metagenomes
|Microbiome|2019|119
Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World
|Chemical Research in Toxicology|2025|99